Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …

Thrombophilias are hereditary and/or acquired conditions that predispose patients to
thrombosis. Testing for thrombophilia is commonly performed in patients with venous …

Venous thromboembolism (VTE) has important heritable components. In the past 20 years,
knowledge in this field has greatly increased with the identification of a number of gene …

The TAM receptor family of TYRO3, AXL and MERTK regulates tissue and immune
homeostasis. Aberrant TAM receptor signalling has been linked to a range of diseases …

Introduction Natural anticoagulants deficiency (antithrombin [AT], protein C [PC], protein S
[PS]) is a rare, but potent risk factor for venous thromboembolism (VTE). We performed a …

Genetic risk factors predispose to thrombophilia and play the most important etiopathogenic
role in venous thromboembolism (VTE) in people younger than 50 years old. At least one …

Venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a significant cause of morbidity and mortality worldwide. There …

The incidence of venous thrombosis is 1–3 individuals per 1000 per year, with a high rate of
complications and death. Men and women are affected about equally by venous thrombosis …

Genetics play a significant role in venous thromboembolism (VTE), yet current clinical
laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden …

The aim of this review is to highlight all the factors that associate venous thromboembolism
(VTE) with aging. Elderly people are characterized by a higher incidence of thrombosis …